Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity
CES1 is associated with an increasing risk of MetS and MASLD and can be established as a biomarker for metabolic syndrome and MASLD of children with obesity.
Authors
- Ling Hou (ORCID: https://orcid.org/0000-0003-2596-9953)
- Xiaoping Luo (ORCID: https://orcid.org/0000-0002-3748-4817)
- Shimin Wu (ORCID: https://orcid.org/0000-0003-2541-6689)
- Yanqin Ying (ORCID: https://orcid.org/0000-0003-4356-0385)
- Ying Weng (ORCID: https://orcid.org/0000-0001-8183-3896)
- Wei Wu (ORCID: https://orcid.org/0000-0001-6984-3581)
- Feng Ye (ORCID: https://orcid.org/0000-0001-6130-1817)
- Huanyu Wang (ORCID: https://orcid.org/0000-0001-6245-2027)
- Xi Yang (ORCID: https://orcid.org/0000-0002-0116-7326)
- Yan Liang
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Hubei University (CN)
Publication Details
- Journal
- The Italian Journal of Pediatrics/Italian journal of pediatrics
- Published
- 2024-09-04
- DOI
- https://doi.org/10.1186/s13052-024-01733-7
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- National Key Research and Development Program of China